Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (721-730 of 850) with videos related to

Pageof 85
Sort By:
European Urology Oncology|July 17, 2025
Years of Life Lost in Metastatic and Locally Advanced Prostate CancerFabian Falkenbach, Quynh Chi Le, Mattia Longoni, et al.
Clinical Genitourinary Cancer|January 25, 2025
Clinically Meaningful Upstaging and Upgrading in Favorable Intermediate-Risk Radical Prostatectomy PatientsMattia Longoni, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
BJU International|July 6, 2013
Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS projectMassimo Lazzeri, Alexander Haese, Alberto Abrate, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 6, 2022
The effect of chemotherapy in sarcomatoid bladder cancer patients treated with radical cystectomyStefano Tappero, Gabriele Sorce, Benedikt Hoeh, et al.
International Journal of Molecular Sciences|December 11, 2022
Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate CancerGunhild von Amsberg, Mirjam Zilles, Wael Mansour, et al.
Aging|September 27, 2019
Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancerStefan Steurer, Benjamin Hager, Franziska Büscheck, et al.
Cancer Epidemiology|February 20, 2024
Survival differences in non-seminoma testis cancer patients according to race/ethnicityReha-Baris Incesu, Francesco Barletta, Stefano Tappero, et al.
BJU International|December 12, 2024
Survival after trimodal therapy in octogenarians with organ-confined urothelial bladder cancerMattia Longoni, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
Surgical Oncology|November 4, 2025
Sarcomatoid dedifferentiation as a predictor of overall mortality in surgically treated metastatic renal cell carcinomaReha-Baris Incesu, Lukas Scheipner, Simone Morra, et al.
The Prostate|September 21, 2017
High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancerChristoph Burdelski, Rami Shihada, Andrea Hinsch, et al.
Pageof 85

Showing results (721-730 of 850) with videos related to

Sort By:
Pageof 85
European Urology Oncology|July 17, 2025
Years of Life Lost in Metastatic and Locally Advanced Prostate CancerFabian Falkenbach, Quynh Chi Le, Mattia Longoni, et al.
Clinical Genitourinary Cancer|January 25, 2025
Clinically Meaningful Upstaging and Upgrading in Favorable Intermediate-Risk Radical Prostatectomy PatientsMattia Longoni, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
BJU International|July 6, 2013
Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS projectMassimo Lazzeri, Alexander Haese, Alberto Abrate, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 6, 2022
The effect of chemotherapy in sarcomatoid bladder cancer patients treated with radical cystectomyStefano Tappero, Gabriele Sorce, Benedikt Hoeh, et al.
International Journal of Molecular Sciences|December 11, 2022
Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate CancerGunhild von Amsberg, Mirjam Zilles, Wael Mansour, et al.
Aging|September 27, 2019
Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancerStefan Steurer, Benjamin Hager, Franziska Büscheck, et al.
Cancer Epidemiology|February 20, 2024
Survival differences in non-seminoma testis cancer patients according to race/ethnicityReha-Baris Incesu, Francesco Barletta, Stefano Tappero, et al.
BJU International|December 12, 2024
Survival after trimodal therapy in octogenarians with organ-confined urothelial bladder cancerMattia Longoni, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
Surgical Oncology|November 4, 2025
Sarcomatoid dedifferentiation as a predictor of overall mortality in surgically treated metastatic renal cell carcinomaReha-Baris Incesu, Lukas Scheipner, Simone Morra, et al.
The Prostate|September 21, 2017
High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancerChristoph Burdelski, Rami Shihada, Andrea Hinsch, et al.
Pageof 85